Carcinoma, Renal Cell: all 1,992 studies
Page 2 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCCRecruitingNCT07197580Phase 3
- A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesRecruitingNCT07195916Phase 1
- A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)RecruitingNCT07195682Phase 1
- Comparison of Outcomes and Surgical Time Between Cortical and Medullary Suture vs. Medullary-Only Suture: Cortex Clinical TrialRecruitingNCT07190638Not applicable
- A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)RecruitingNCT07188896Phase 2
- Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept StudyRecruitingNCT07187869Phase 1
- Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)RecruitingNCT07187778Phase 2
- PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate RiskRecruitingNCT07175480Phase 2
- A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT07172802Phase 1/2
- Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCCRecruitingNCT07172386Phase 2
- Targeted Abdominal CT in Conjunction With Lung Cancer ScreeningRecruitingNCT07171190Not applicable
- Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialRecruitingNCT07167329Phase 2
- Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CTRecruitingNCT07166445
- A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKINot yet recruitingNCT07165418Phase 3
- Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell CancerRecruitingNCT07128680Phase 1
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaRecruitingNCT07123090Phase 2
- Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical TreatmentRecruitingNCT07118813
- Validation of RCC Predicting Model With Emulated-target TrialRecruitingNCT07117227
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruitingNCT07115043Phase 1/2
- 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesEnrolling by invitationNCT07101900Phase 2
- R.E.C.K vs Exparel in Robotic NephrectomyRecruitingNCT07092566Phase 3
- A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell CarcinomaRecruitingNCT07087158Phase 2
- Cabozantinib Dose Skipping as an Alternative to Dose ReductionsRecruitingNCT07077161Phase 2
- CAIX PET/CT for Residual or Recurrent Post-ablative ccRCCNot yet recruitingNCT07077083Phase 2
- Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.RecruitingNCT07073703Not applicable
- Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell CarcinomaRecruitingNCT07067905Early Phase 1
- Kidney-protective Intervention With Salt Substitute After Kidney Tumor SurgeryRecruitingNCT07062952Not applicable
- Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal CellRecruitingNCT07062549Phase 1
- CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection RiskRecruitingNCT07053462Phase 1/2
- Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)RecruitingNCT07049926Phase 1/2
- Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue BiopsyEnrolling by invitationNCT07046832Not applicable
- Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone MetastasesRecruitingNCT07043608Phase 2
- Investigation of Lymph Node Biology in Kidney CancerRecruitingNCT07038733Not applicable
- Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After SurgeryRecruitingNCT07037004Phase 2
- Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal CarcinomaRecruitingNCT07028125Phase 4
- Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)RecruitingNCT07023432Phase 2
- Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation StudyRecruitingNCT07020169Not applicable
- Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell CarcinomaRecruitingNCT07018037
- Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current ManagementRecruitingNCT06995664Not applicable
- Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without ImmunotherapyNot yet recruitingNCT06976021Phase 2
- Study of DCC-2812 in Participants With Advanced Genitourinary CancersRecruitingNCT06966024Phase 1
- Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)RecruitingNCT06960798
- Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer SurgeryNot yet recruitingNCT06960174Not applicable
- Lu-177 PSMA Treatment in Cell Renal CarcinomaNot yet recruitingNCT06959433Phase 3
- Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer PatientsRecruitingNCT06956144
- Imaging of Solid Tumors Using 18F-TRXRecruitingNCT06942104Phase 1
- Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell CarcinomaRecruitingNCT06940518Phase 2
- Cabozantinib and Nivolumab Among Older Patients With Renal Cell CarcinomaRecruitingNCT06934057Phase 4
- Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell CarcinomaRecruitingNCT06916624
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal TumorsRecruitingNCT06908902Not applicable
- Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.RecruitingNCT06903312Phase 4
- Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitisRecruitingNCT06899789
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsEnrolling by invitationNCT06885424
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.RecruitingNCT06883539Phase 1
- A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCCNot yet recruitingNCT06870279Phase 1
- Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational PlatformRecruitingNCT06868927
- A Multicenter Study of RUS NERecruitingNCT06868186Not applicable
- Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON TrialRecruitingNCT06866262Phase 1/2
- Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal CancerRecruitingNCT06863857
- Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCCRecruitingNCT06863311Phase 2
- CD70-targeted immunoPET Imaging of Malignant CancersRecruitingNCT06852638Phase 2
- A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesRecruitingNCT06839105Phase 1
- A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)RecruitingNCT06835972Phase 1/2
- A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitRecruitingNCT06805825Phase 1
- A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsRecruitingNCT06792552Phase 1
- Study of the Prognostic Impact of CD44 on Renal Cell CarcinomaNot yet recruitingNCT06773377
- Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)RecruitingNCT06770855Not applicable
- A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT ImagingRecruitingNCT06769893Not applicable
- A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant TumorsRecruitingNCT06764771Phase 1
- The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective StudyRecruitingNCT06751498
- 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP StudyRecruitingNCT06750419Phase 3
- Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsRecruitingNCT06750185Phase 1/2
- Clinicopathological Features of Renal Cell Carcinoma in Young PatientsNot yet recruitingNCT06730997
- An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With EverolimusRecruitingNCT06730672Phase 2
- Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)RecruitingNCT06726421Phase 3
- Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.RecruitingNCT06724159
- Optimising Renal Tumour Management Through Artificial Intelligence ModulesRecruitingNCT06714916
- A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaRecruitingNCT06699602Phase 2
- Combination of Toripalimab and JS004 Therapy for ccRCCRecruitingNCT06690697Phase 2
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionRecruitingNCT06682793Phase 1/2
- CD70-targeted immunoPET Imaging of Kidney CancerRecruitingNCT06680089Phase 2
- Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaRecruitingNCT06676527
- Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal CancerNot yet recruitingNCT06670300Phase 2
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerRecruitingNCT06661720Phase 3
- Ablative Radioembolization of Renal Cell Carcinoma TrialRecruitingNCT06642220Phase 2
- 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.RecruitingNCT06613269Phase 2
- Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney CancerRecruitingNCT06601296Phase 2
- A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell CarcinomaNot yet recruitingNCT06585878Not applicable
- SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal CancerRecruitingNCT06583070
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC PatientsNot yet recruitingNCT06577961Phase 1/2
- A Study of HS-10516 in Patients With VHL Syndrome Associated TumorsRecruitingNCT06553339Phase 1
- Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinibRecruitingNCT06548867
- Planning Operative Strategy Using a Digital Renal Artery Clamping ToolRecruitingNCT06536439Not applicable
- Rein 3D PRINT MECHANICSRecruitingNCT06525831Not applicable
- Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination TherapyNot yet recruitingNCT06523049Phase 2
- 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell CarcinomaRecruitingNCT06519760Not applicable
- A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell CarcinomaNot yet recruitingNCT06472895Phase 1/2